MetLife Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $633K | Sell |
|
|||||
|
2023
Q3 | $343K | Hold |
|
|||||
|
2023
Q2 | $440K | Sell |
|
|||||
|
2023
Q1 | $3.09M | Buy |
|
|||||
|
2022
Q4 | $3.11M | Hold |
|
|||||
|
2022
Q3 | $3.56M | Buy |
|
|||||
|
2022
Q2 | $1.73M | Buy |
|
|||||
|
2022
Q1 | $1.56M | Buy |
|
|||||
|
2021
Q4 | $1.05M | Hold |
|
|||||
|
2021
Q3 | $979K | Hold |
|
|||||
|
2021
Q2 | $912K | Buy |
|
|||||
|
2021
Q1 | $723K | Sell |
|
|||||
|
2020
Q4 | $702K | Hold |
|
|||||
|
2020
Q3 | $535K | Hold |
|
|||||
|
2020
Q2 | $771K | Buy |
|
|||||
|
2020
Q1 | $334K | Buy |
|
|||||
|
2019
Q4 | $171K | Buy |
|